Table 1.

Change in tumor measurements, grouped by mutation status, for each measurement method

All tumorsEGFR mutantEGFR WT*P
N482127
Unidimensional percentage change (%)
    Median−5.3−11.1−1.80.002
    IQR−13.1, 0.7−26.9, −4.4−7.0, 1.3
Volumetric percentage change (%)
    Median−23.9−45.9−4.4<0.001
    IQR−44.8, 0.0−54.1, −29.1−16.5, 7.0

NOTE: P values are from a Wilcoxon rank-sum test comparing EGFR mutant tumors versus EGFR WT tumors.

Abbreviation: IQR, interquartile range.

  • *Includes all KRAS mutant tumors.